"TIDES is the premier venue to network with the experts in peptide and oligonucleotide development and to be on the pulse of current status and future trends in Biotech and Pharma." - Alex Fӓssler, Ph.D., COO Europe, Bachem AG, Switzerland
"TIDES is an excellent opportunity to connect with the Oligo Industry, staying abreast of the latest developments while formulating strategies for the future." - Giuseppe Whelan, Project Leader, GlaxoSmithKline
"One of the great things about TIDES, in addition to the excellent program content, is the large exhibit hall which enables me to meet with many of the most relevant suppliers with just one trip." - Christoph Rosenbohm, Ph.D., Senior Director, Research Operations, Santaris Pharma A/S, Denmark
"Very interesting presentations from industry and academia make TIDES an excellent opportunity to know the hot-topics in peptide therapeutics. The dynamic, friendly atmosphere creates good networking opportunities." - Jose De Chastonay, Ph.D., MBA, Chief Marketing Officer, Bachem Group
"The TIDES series of conferences is an indispensable catalyst for the industry to bring people together to share knowledge and address topics of common interest and ensure that we can help our business and the industry to grow and flourish... It's a special, special event. I always enjoy myself and find it incredibly enriching." - Lester Mills, Ph.D., MBA, Head of M&A, BASF
Stanley T. Crooke, M.D., Ph.D.
Isis Pharmaceuticals, Inc.
John Maraganore, Ph.D.
Torsten Hoffmann, Ph.D.
Zealand Pharma A/S, Denmark
Kunwar Shailubhai, Ph.D.
Synergy Pharmaceuticals, Inc.
May 3-6, 2015
Town and Country Hotel
San Diego, CA